These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22554253)

  • 61. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
    Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
    Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early Aβ-HBc virus-like particles immunization had better effects on preventing the deficit of learning and memory abilities and reducing cerebral Aβ load in PDAPP mice.
    Feng G; Zheng C; Hui J
    Vaccine; 2018 Aug; 36(35):5258-5264. PubMed ID: 30055971
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
    Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
    Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
    Jäkel L; Boche D; Nicoll JAR; Verbeek MM
    Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4-10 Prevents Spatial Learning Decline.
    Kawarabayashi T; Terakawa T; Takahashi A; Hasegawa H; Narita S; Sato K; Nakamura T; Seino Y; Hirohata M; Baba N; Ueda T; Harigaya Y; Kametani F; Maruyama N; Ishimoto M; St George-Hyslop P; Shoji M
    J Alzheimers Dis; 2019; 70(2):487-503. PubMed ID: 31177217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
    Britschgi M; Olin CE; Johns HT; Takeda-Uchimura Y; LeMieux MC; Rufibach K; Rajadas J; Zhang H; Tomooka B; Robinson WH; Clark CM; Fagan AM; Galasko DR; Holtzman DM; Jutel M; Kaye JA; Lemere CA; Leszek J; Li G; Peskind ER; Quinn JF; Yesavage JA; Ghiso JA; Wyss-Coray T
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12145-50. PubMed ID: 19581601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cessation of neoangiogenesis in Alzheimer's disease follows amyloid-beta immunization.
    Biron KE; Dickstein DL; Gopaul R; Fenninger F; Jefferies WA
    Sci Rep; 2013; 3():1354. PubMed ID: 23446889
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.
    Carrera I; Etcheverría I; Fernández-Novoa L; Lombardi VR; Lakshmana MK; Cacabelos R; Vigo C
    Biomed Res Int; 2015; 2015():807146. PubMed ID: 25759822
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.
    Lin X; Bai G; Lin L; Wu H; Cai J; Ugen KE; Cao C
    Hum Vaccin Immunother; 2014; 10(7):2024-31. PubMed ID: 25424812
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer's mice.
    Luo Z; Li J; Nabar NR; Lin X; Bai G; Cai J; Zhou SF; Cao C; Wang J
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):640-55. PubMed ID: 22684353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
    Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
    J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel Abeta immunogens: is shorter better?
    Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
    Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice.
    Li Y; Ma Y; Zong LX; Xing XN; Guo R; Jiang TZ; Sha S; Liu L; Cao YP
    J Neuroimmunol; 2012 Aug; 249(1-2):16-26. PubMed ID: 22626444
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.
    Cao C; Lin X; Wahi MM; Jackson EA; Potter H
    BMC Neurosci; 2008 Feb; 9():25. PubMed ID: 18282292
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42).
    Town T; Vendrame M; Patel A; Poetter D; DelleDonne A; Mori T; Smeed R; Crawford F; Klein T; Tan J; Mullan M
    J Neuroimmunol; 2002 Nov; 132(1-2):49-59. PubMed ID: 12417433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
    Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.
    Axelsen TV; Holm A; Christiansen G; Birkelund S
    Vaccine; 2011 Apr; 29(17):3260-9. PubMed ID: 21371581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.